InhaltsangabeIntroductionDiabetic Retinopathy - what we know, don't know, and need to know - Tom GardnerLiving with Diabetic Retinopathy Ch. 1 A Patient's viewpoint: Heather StuckeyCh. 2 What patients with diabetes see-and don't see: subjective and objective visual functionchanges - Shelly BoydCh. 3 How do I know I have diabetic retinopathy - a clinician's view? - David QuillenPrevalence, Public Awareness, and Screening Methods Ch. 4 Epidemiology & Economics - John Javitt Ch. 5 Correlation between the presence and severity of diabetic retinopathy in families with diabetes- Victor Gonzalez Ch. 6 Increasing public awareness of the diabetes endemic - Ian ConstableCh. 7 Nutrition and diabetes- David NathanCh. 8 Diabetic retinopathy screening - progress and complications - Peter Scanlon Diagnosing Diabetic Retinopathy Ch. 9 Measurements of retinal blood flow, vascular leakage, and oxygenation - Einer StefanssonCh. 10 Optical imaging - Confocal microscopy to detect retinal vasculature - Martin FriedlanderCh. 11 Structural imaging - OCT - M. LarsenCh. 12 Functional imaging - ERG - Anthony Adams How Diabetes Affects the EyeCh. 13 Clinical phenotypes (reclassification) - J. Cunha-VazCh. 14 Vascular changes - David Antonetti & Tom Gardiner (Belfast)Ch. 15 Neuronal changes - Alistair Barber/Greg JacksonCh. 16 Inflammatory changes - Mark TsoCh. 17 Other Ocular Complications of Diabetes - Shoja MR New Approaches to Diabetic RetinopathyCh. 18 New insights in the pathogenesis of diabetic retinopathy using a proteomic approach - Retina -Quin GGCh. 19 Vitreous proteomics - Ed FeenerCh. 20 Genomics - Bill FreemanCh. 21 Genome-wide linkage analyses to identify Loci for diabetic retinopathy - Kang Zhang (Utah)Risk Factors Ch. 22 Diabetic retinopathy correlates with increased incidence of cardiovascular events -Cheung NCh. 23 Pregnancy and rate of progression of diabetic retinopathy - Sheth BP Molecular Mechanisms that Could Trigger Visual Dysfunction in DiabetesIntroduction - Tom GardnerCh. 24 Inflammation in the early pathogenesis of diabetic retinopathy -beauty and beast. - Chris Norbury (Hershey)Ch. 25 Oxidative stress and diabetic retinopathy. - Catherine WhitesideCh. 26 Glucose induced cellular signaling in diabetic retinopathy - Chakrabarti SCh. 27 The AGE/RAGE axis in early diabetic retinopathy - Schmidt AMCh. 28 Proteases and the retinal vasculature (and maybe the whole retina!) - Arup Das.Ch. 29 IGFBP3 and retinal vessel growth. Smith LECh. 30 PEDF, VEGF, CTGF review - JX MaCh. 31 A decrease in the expression of somatostatin is an early event in diabetic retinopathy -Carrasco ECh. 32 Connective tissue and connective tissue growth factor in diabetic retinopathy - SchlingemannROCh. 33 Molecular regulation of endothelial cell tight junctions and the blood retinal barrier - AntonettiDACh. 34 Pericytes and diabetic retinopathy - Puro DGCh. 35 Leukostasis - Adamis, APCh. 36 Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. -Khalfaoui T, Ch. 37 Azurocidin as a Permeability Factor in the Retina - Hafezi-Moghadam ACh. 38 Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucoseprovocation in early sight-threatening diabetic retinopathy. - Devenyi RG.Ch. 39 Urinary 8-hydroxydeoxyguanosine (8-OHdG) levels in diabetic retinopathy patients. - SteveAbcouwerCh. 40 Tyrosine nitration in the molecular mechanisms of diabetic retinopathy. - Crabb J

InhaltsangabeIntroductionDiabetic Retinopathy - what we know, don't know, and need to know - Tom GardnerLiving with Diabetic Retinopathy Ch. 1 A Patient's viewpoint: Heather StuckeyCh. 2 What patients with diabetes see-and don't see: subjective and objective visual functionchanges - Shelly BoydCh. 3 How do I know I have diabetic retinopathy - a clinician's view? - David QuillenPrevalence, Public Awareness, and Screening Methods Ch. 4 Epidemiology & Economics - John Javitt Ch. 5 Correlation between the presence and severity of diabetic retinopathy in families with diabetes- Victor Gonzalez Ch. 6 Increasing public awareness of the diabetes endemic - Ian ConstableCh. 7 Nutrition and diabetes- David NathanCh. 8 Diabetic retinopathy screening - progress and complications - Peter Scanlon Diagnosing Diabetic Retinopathy Ch. 9 Measurements of retinal blood flow, vascular leakage, and oxygenation - Einer StefanssonCh. 10 Optical imaging - Confocal microscopy to detect retinal vasculature - Martin FriedlanderCh. 11 Structural imaging - OCT - M. LarsenCh. 12 Functional imaging - ERG - Anthony Adams How Diabetes Affects the EyeCh. 13 Clinical phenotypes (reclassification) - J. Cunha-VazCh. 14 Vascular changes - David Antonetti & Tom Gardiner (Belfast)Ch. 15 Neuronal changes - Alistair Barber/Greg JacksonCh. 16 Inflammatory changes - Mark TsoCh. 17 Other Ocular Complications of Diabetes - Shoja MR New Approaches to Diabetic RetinopathyCh. 18 New insights in the pathogenesis of diabetic retinopathy using a proteomic approach - Retina -Quin GGCh. 19 Vitreous proteomics - Ed FeenerCh. 20 Genomics - Bill FreemanCh. 21 Genome-wide linkage analyses to identify Loci for diabetic retinopathy - Kang Zhang (Utah)Risk Factors Ch. 22 Diabetic retinopathy correlates with increased incidence of cardiovascular events -Cheung NCh. 23 Pregnancy and rate of progression of diabetic retinopathy - Sheth BP Molecular Mechanisms that Could Trigger Visual Dysfunction in DiabetesIntroduction - Tom GardnerCh. 24 Inflammation in the early pathogenesis of diabetic retinopathy -beauty and beast. - Chris Norbury (Hershey)Ch. 25 Oxidative stress and diabetic retinopathy. - Catherine WhitesideCh. 26 Glucose induced cellular signaling in diabetic retinopathy - Chakrabarti SCh. 27 The AGE/RAGE axis in early diabetic retinopathy - Schmidt AMCh. 28 Proteases and the retinal vasculature (and maybe the whole retina!) - Arup Das.Ch. 29 IGFBP3 and retinal vessel growth. Smith LECh. 30 PEDF, VEGF, CTGF review - JX MaCh. 31 A decrease in the expression of somatostatin is an early event in diabetic retinopathy -Carrasco ECh. 32 Connective tissue and connective tissue growth factor in diabetic retinopathy - SchlingemannROCh. 33 Molecular regulation of endothelial cell tight junctions and the blood retinal barrier - AntonettiDACh. 34 Pericytes and diabetic retinopathy - Puro DGCh. 35 Leukostasis - Adamis, APCh. 36 Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. -Khalfaoui T, Ch. 37 Azurocidin as a Permeability Factor in the Retina - Hafezi-Moghadam ACh. 38 Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucoseprovocation in early sight-threatening diabetic retinopathy. - Devenyi RG.Ch. 39 Urinary 8-hydroxydeoxyguanosine (8-OHdG) levels in diabetic retinopathy patients. - SteveAbcouwerCh. 40 Tyrosine nitration in the molecular mechanisms of diabetic retinopathy. - Crabb J